...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Breast conservative therapy in east part of China: a retrospective cohort study.
【24h】

Breast conservative therapy in east part of China: a retrospective cohort study.

机译:中国东部地区的乳腺癌保守治疗:一项回顾性队列研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To compare the effects of breast conservative therapy (BCT) with modified radical mastectomy (MRM) in women with early stage breast cancer in the east part of China. We conducted a matched retrospective cohort study using data on patients derived from a prospectively collected breast cancer database. METHODS: We used the database that included patients who received MRM or BCT from 1995 to 2002 in our hospital. The match was conducted according to four variables: age at diagnosis, axillary lymph node status, hormone receptor status, and the dimension of tumor. The match ratio was 1:2. MRM group were patients who received MRM treatment (n=254). BCT group were patients who received BCT treatment (n=127). Median follow-up time for the BCT group and MRM group were 58 and 49 months, respectively. The differences of incidence of loco-regional recurrence, disease free survival, and overall survival at 5 years were compared. RESULTS: There were no significant differences in incidence of loco-regional recurrence, DFS and OS at 5 years between the two groups of patients. The incidence of loco-regional recurrence was 1.84% in MRM group and 3.39% in BCT group (P=0.55). The DFS in MRM and BCT patients were 91.57 and 86.04% (P=0.37); the OS in MRM and BCT patient were 97.57 and 96.73% (P=0.66). CONCLUSIONS: For appropriate breast cancer patients, classic lumpectomy plus axillary dissection and postoperative radiotherapy lead to excellent local control and good survival rate in our study. The BCT can result in the same effects as MRM in Chinese breast cancer patients with better cosmetic appearances.
机译:目的:比较中国东部地区早期乳腺癌女性乳腺癌保守治疗(BCT)和改良根治术(MRM)的疗效。我们使用来自前瞻性收集的乳腺癌数据库的患者数据进行了一项回顾性队列研究。方法:我们使用的数据库包括1995年至2002年在我院接受MRM或BCT的患者。根据四个变量进行匹配:诊断时的年龄,腋窝淋巴结状态,激素受体状态以及肿瘤的大小。匹配率为1:2。 MRM组为接受MRM治疗的患者(n = 254)。 BCT组为接受BCT治疗的患者(n = 127)。 BCT组和MRM组的中位随访时间分别为58个月和49个月。比较了5年局部复发率,无病生存率和总生存率的差异。结果:两组患者在5年时局部区域复发,DFS和OS的发生率无显着差异。 MRM组和BCT组局部复发率分别为1.84%和3.39%(P = 0.55)。 MRM和BCT患者的DFS分别为91.57和86.04%(P = 0.37); MRM和BCT患者的OS分别为97.57和96.73%(P = 0.66)。结论:对于合适的乳腺癌患者,在我们的研究中,经典的肿块切除术加上腋窝淋巴结清扫术和术后放疗可导致出色的局部控制和良好的生存率。 BCT在具有更好外观的中国乳腺癌患者中可产生与MRM相同的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号